renal dysplasia, bilateral
ORPHA: 931731 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| Angiotensin-Converting Enzyme Inhibitors (Enalapril) | Oral tablet 2.5mg, 5mg, 10mg, 20mg; IV injection 1.25mg/mL | FDA Approved, EMA Approved | 10 | 2d |
Classification & Codes
Orphanet Code
ORPHA:93173renal dysplasia, bilateral
| Orphanet | ORPHA:93173 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO